Related references
Note: Only part of the references are listed.Microfluidic extraction and microarray detection of biomarkers from cancer tissue slides
H. T. Nguyen et al.
JOURNAL OF MICROMECHANICS AND MICROENGINEERING (2018)
Breast cancer HER2 analysis by extra-short incubation microfluidics-assisted fluorescence in situ hybridization (ESIMA FISH)
Huu Tuan Nguyen et al.
MICROELECTRONIC ENGINEERING (2018)
Microfluidics-assisted fluorescence in situ hybridization for advantageous human epidermal growth factor receptor 2 assessment in breast cancer
Huu Tuan Nguyen et al.
LABORATORY INVESTIGATION (2017)
Proof of the quantitative potential of immunofluorescence by mass spectrometry
Maria I. Toki et al.
LABORATORY INVESTIGATION (2017)
Microfluidic-assisted chromogenic in situ hybridization (MA-CISH) for fast and accurate breast cancer diagnosis
Huu Tuan Nguyen et al.
MICROELECTRONIC ENGINEERING (2017)
Relevance of deep learning to facilitate the diagnosis of HER2 status in breast cancer
Michel E. Vandenberghe et al.
SCIENTIFIC REPORTS (2017)
Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity
Qing Zhong et al.
SCIENTIFIC REPORTS (2016)
Quantification of HER2 heterogeneity in breast cancer-implications for identification of sub-dominant clones for personalised treatment
Niamh E. Buckley et al.
SCIENTIFIC REPORTS (2016)
Continuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancer
Diego G. Dupouy et al.
SCIENTIFIC REPORTS (2016)
Fully Automated Fluorescent in situ Hybridization (FISH) Staining and Digital Analysis of HER2 in Breast Cancer: A Validation Study
Elise M. J. van der Logt et al.
PLOS ONE (2015)
HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity
Wedad M. Hanna et al.
MODERN PATHOLOGY (2014)
Cancer heterogeneity: implications for targeted therapeutics
R. Fisher et al.
BRITISH JOURNAL OF CANCER (2013)
Semi-automatic FISH quantification on digital slides
Gábor Kiszler et al.
Diagnostic Pathology (2013)
Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens
Daniela Furrer et al.
DIAGNOSTIC PATHOLOGY (2013)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Microfluidic processor allows rapid HER2 immunohistochemistry of breast carcinomas and significantly reduces ambiguous (2+) read-outs
Ata Tuna Ciftlik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Comparison of automated and manual FISH for evaluation of HER2 gene status on breast carcinoma core biopsies
Christian Oehlschlegel et al.
BMC CLINICAL PATHOLOGY (2013)
'Genetic heterogeneity' in HER2/neu testing by fluorescence in situ hybridization: a study of 2522 cases
Martin C. Chang et al.
MODERN PATHOLOGY (2012)
Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance
Hyesil Seol et al.
MODERN PATHOLOGY (2012)
Evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue
Steven J. Potts et al.
LABORATORY INVESTIGATION (2012)
Diagnostic Value of Automated Her2 Evaluation in Breast Cancer A Study on 272 Equivocal (score 2+) Her2 Immunoreactive Cases Using an FDA Approved System
Chiara Cantaloni et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2011)
Automated Duet spot counting system and manual technologist scoring using dual-fusion fluorescence in situ hybridization (D-FISH) strategy: comparison and application to FISH minimal residual disease testing in patients with chronic myeloid leukemia
Ryan A. Knudson et al.
CANCER GENETICS AND CYTOGENETICS (2007)
Share Paper
